Navigating the U.S. CDMO Industry
Navigating the Future
Digital Quality Management Systems as Strategic Enablers of Patient-Centric Manufacturing Excellence
The Increasing Importance of Manufacturability in API Development
Rise of AI ML-Powered Accelerators in Pharma Secure Supply Chain
EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Pharmacovigilance in the GLP-1 Era: Safety Surveillance Challenges for Obesity Medicines and Real-World Use
The rapid uptake of GLP therapies is pushing pharmacovigilance beyond traditional slower models built for smaller and more controlled treatment popula...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
Forgotten Biology: The Missing Link Behind Trial Outcomes
Clinical trials are often described as the science of uncertainty and that uncertainty is expected It is how evidence is built However not all uncertainty is scientific In many cases it arises when the biological context of an intervention is not carried through into the study population
-
Techno Trends
Terns Pharmaceuticals Secures FDA Breakthrough Therapy Designation for TERN-701 in CML
Terns Pharmaceuticals Inc has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration for TERN a novel oral allosteric BCRABL inhibitor
-
Projects
PCI Pharma Services Expands Global Manufacturing Network with $1B+ Investment in San Diego
PCI Pharma Services has announced an investment programme exceeding billion across its US and European operations to strengthen sterile fillfinish and advanced drug delivery capabilities
-
Research Insights
Interpretable multivariate survival models: Improving predictions for conversion from mild cognitive impairment to Alzheimer’s disease via data fusion and machine learning
Accurately predicting which individuals with mild cognitive impairment MCI will progress to Alzheimers disease AD can improve patient care This study examines the role of quantitative MRI qMRI cognitive evaluations
-
White Papers
Accelerating In-Vitro Antibody Discovery with Artificial Intelligence
Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities
TOP ARTICLES
-
1
Innovative Biosafety Testing: Driving Manufacturing Excellence
Kate Williamson
Innovative Biosafety Testing: Driving Manufacturing Excellence explores the pivotal role of advanced biosafety testing in ensuring product safety, regulatory compliance, and market competitiveness in...
-
2
Navigating the Storm: Emerging Challenges in the Pharmaceutical Industry
Kate Williamson
The pharmaceutical industry faces significant challenges, including regulatory complexities, pricing pressures, supply chain disruptions, technological advancements, and antimicrobial resistance. Navi...
-
3
Patient-Centric Approaches in Clinical Trials
Vasudev Bhupathi
Patient-centric clinical trials embed participants’ needs at every stage, co-designed protocols, decentralized visits, digital health tools, diversity metrics, and transparent results. This para...
-
4
Decoding the Magic Number for Vaccine Booster Doses to Combat COVID-19: Why the Race for Developing New SARS-CoV-2 Vaccines Is Far from Over
Ryan Varghese Mathew
Rushil Dalal
Jainam Karsiya
Dileep Kumar
Since the declaration of the SARS-CoV-2 or COVID-19 outbreak as a global pandemic by the World Health Organization, in March 2020, several prevention and treatment strategies have been devised since t...
-
5
Biosimilar Market Access: Why Execution Gaps Cost Companies Hundreds of Millions
Doug Drysdale
The biosimilar market has generated over USD 56.2 billion in savings since 2015, yet many biosimilar companies systematically underperform on market access. This article examines four critical failure...
press releasesRead more...
Lilly announces three acquisitions to build infectious disease portfolio
Eli Lilly and Company today announced agreements to acquire three companies Curevo Inc Curevo LimmaTech Biologics AG LimmaTech Biologics and Vaccine Company Inc Vaccine Company that expand
Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China
INOVIO a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPVrelated diseases cancer and infectious diseases
Whitehawk Therapeutics Expands ADC Pipeline with New Option Agreement for Use of CPT113 Linker-Payload
Whitehawk Therapeutics Inc Nasdaq WHWK a clinicalstage oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved antibody drug conjugate ADC
Mabwell Announces NMPA Approval of Supplemental Application for Additional Indications of MAIWEIJIAN (Denosumab Injection)
Mabwell SH HK an innovationdriven biopharmaceutical company with a fully integrated industry chain announced that the supplemental application for MAIWEIJIAN Denosumab Injection RD code
Events Read more...
27 - 28
May 2026Future Labs Live 2026
Congress Center, Basel, Switzerland
27 - 28
May 2026UK Biotech Day 2026
Radisson Hotel & Conference Centre London Heathrow, UK
27 - 28
May 2026Digi-Tech Pharma & AI Conference
London, United Kingdom
27 - 28
May 2026Global Clinical Trials Connect 2026
London, United Kingdom
01 - 02
Jun 2026Future Pharma 2026
Renaissance Seaport District, Boston, MA, USA
02 - 04
Jun 2026CPHI Americas 2026
Pennsylvania Convention Center, Philadelphia, USA
04 - 05
Jun 2026Pharmac South 2026
Chennai Trade Centre, Nandambakkam, India
04 - 06
Jun 2026Global Bioprocessing Summit & Exhibition 2026
Berlin, Germany
LATEST NEWSRead more...
Collaborative Drug Discovery Partners with Lilly TuneLab to Integrate AI Models into CDD Vault
Collaborative Drug Discovery CDD a provider of data management solutions for the pharmaceutical and biotechnology sectors has entered into an agreement with Eli Lilly and Company to integrate Lilly TuneLab into CDD Vault
BioCareSD partners with WeInfuse to expand infusion technology capabilities
BioCareSD has entered into a partnership with WeInfuse to strengthen technology support for infusion practices and pharmacies across the United States
MEKanistic Therapeutics receives FDA clearance for MTX-531 cancer therapy trial
MEKanistic Therapeutics has received clearance from the US Food and Drug Administration for its Investigational New Drug IND application for MTX allowing the company to begin a Phase clinical trial in advanced solid tumours
Bio-Thera Solutions’ Golimumab Biosimilars Receive FDA Approval in the US
BioThera Solutions and Accord BioPharma have announced that the US Food and Drug Administration FDA has approved IMMGOLIS golimumabsldi and IMMGOLIS INTRI golimumabsldi the first biosimilars to Simponi and Simponi Aria in the United States
Dr. Reddy’s launches generic Semaglutide injection in Canada
Dr Reddys Laboratories has launched its generic Semaglutide Injection in Canada after receiving approval from Health Canada on April The company is among the first to introduce a generic version
Lilly and UNICEF collaborate to support children’s health in low- and middle-income countries
Eli Lilly and Company and UNICEF USA have announced a new collaboration to improve prevention and care for noncommunicable diseases NCDs among children and adolescents in low and middleincome countries
